Boards 3 April 2017 - Executive Committee

03 April 2017

READING, UNITED KINGDOM (3 April 2017) — It is with deep regret that the Company announces the death of Mike Sgrignari, Executive Vice President, Operations and member of the Executive Committee of ConvaTec Group Plc.

Paul Moraviec, Chief Executive Officer, said:

“Mike was a hugely talented executive who made a significant and valuable contribution to the development and performance of the Company. On behalf of the management and employees of Convatec I wish to publicly express our condolences to Mike’s family, colleagues both past and present and friends, for their loss.”

Since joining Convatec in 2015, Mike has built a strong and highly experienced team which will continue to focus on the execution of the Company’s Margin Improvement Programme.

Robert Steele, Executive Vice President, Quality, Regulatory & Clinical Affairs will assume interim responsibility for the Operations function.

Enquiries

Convatec

Bobby Leach, VP Group Corporate Affairs +44 (0)7770 842226

Kirsty Law, Director Investor Relations +44 (0)7470 909582

Finsbury

Rebecca Fitchett +44 (0)207 2513801

About Convatec

Convatec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about Convatec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

“Nordic Capital” refers to Nordic Capital VII Limited, acting in its capacity as General Partner of Nordic Capital VII Alpha, L.P. and Nordic Capital VII Beta, L.P. together with associated co-investment vehicles and Nordic Capital VI Limited, acting in its capacity as General Partner of Nordic Capital VI Alpha, L.P. and Nordic Capital VI Beta, L.P. together with associated co-investment vehicles.

“Avista” is the limited liability companies and limited partnerships managed by Avista Capital Managing Member, LLC with interests in ConvaTec, including Avista Capital Partners LP, Avista Capital Partners II LP and their affiliated funds and co-invest vehicles.

Press Release

See all

04-Dec-17

Corporate

Our People

Organisation Appointments

16-Oct-17

Corporate

Financial Performance

FY2017 guidance and third quarter update

19-Sep-17

Continence Care

Convatec Introduces GentleCath™ Glide and me+™ Continence Care Programme for Intermittent Catheter Users in Europe

11-Sep-17

Corporate

Financial Performance

Scrip Dividend

21-Aug-17

Corporate

Our People

Appointment to Executive Committee

14-Aug-17

Corporate

Our People

Convatec appoints two Non-Executive Directors

03-Aug-17

Ostomy Care

Convatec Launches Natura™ Convex Accordion Flange™, Designed to Make Ostomy Pouch Application Easier and More Comfortable

03-Aug-17

Corporate

Convatec Announces 2017 Interim results

03-Aug-17

Corporate

Our People

Board Changes

20-Jul-17

Corporate

Continence Care

Convatec Announces Acquisition of Woodbury Holdings

09-Jun-17

Corporate

Our People

Announcement on Board of Directors

04-May-17

Corporate

Financial Performance

Trading Update for the three months ended 31 March 2017

02-May-17

Ostomy Care

Convatec Announces U.S. FDA 510(k) Clearance and Launch of Flexi-Seal™ PROTECT Fecal Management System

07-Apr-17

Advanced Wound Care

Independent Study Finds Significant Decrease in Post-Operative Joint Infections with AQUACEL® Ag SURGICAL Cover Dressing

05-Apr-17

Advanced Wound Care

Convatec Announces U.S. Launch of Foam Lite™ ConvaTec Dressing, Providing Customers with Wider Choice for Variety of Wounds

03-Apr-17

Corporate

Our People

Boards 3 April 2017 - Executive Committee